A new study reports neuromelanin sensitive MRI is able to measure dopamine function associated with psychosis.
The stress of the COVID-19 pandemic may lead to an increased risk of developing psychosis for some people. Additionally, contracting the coronavirus infection may lead to some people developing symptoms of psychosis.
Exposure to nitrogen dioxide and nitrogen oxides through air pollution is linked to an increased risk of experiencing psychotic symptoms in teenagers. Accounting for other known risk factors, exposure to both NO2 and NOx accounted for 60% of the link between symptoms of psychosis and living in an urban environment.
Researchers have discovered a gene that could help to identify marijuana users most at risk for developing symptoms of psychosis. The study also reports female users are more susceptible to short term memory loss than males.
A new study confirms a link between a number of autoimmune diseases and an increased risk of developing psychosis.
A cluster of epigenetic marks in an enhancer at IGF2 could enhance dopamine synthesis associated with psychosis in schizophrenia and bipolar disorder. The findings may help in devising more effective treatments and screening strategies for both disorders.
Elevated glycine levels are associated with the onset of psychosis, a new study reports.
A new study reports that 24 hours of sleep deprivation can lead to symptoms similar to schizophrenia in healthy people.
Researchers were able to reverse the neural and behavioral effects of THC exposure and eliminate schizophrenia like symptoms in rats by using drugs to activate GABA, a new study reports.
Neuroimaging study finds significant changes in the brain associated with mental illnesses that could serve as a biomarker for diagnosis.
Brain scans revealed, compared to women with low risk for postpartum psychosis, new mothers in high-risk groups had altered brain connectivity in networks associated with goal-orientated behaviors.
Neurostimulation implants used to treat drug-resistant epilepsy also help to reduce mental health symptoms in patients.
